These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32683184)

  • 1. Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Li YM; Luo RH; Yang LM; Huang SM; Li SY; Zheng YG; Ni DX; Cui YM; Zhang XJ; Li XL; Zhang RH; Tang E; Zhang HB; Zheng YT; He YP; Xiao WL
    Bioorg Chem; 2020 Sep; 102():104041. PubMed ID: 32683184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
    Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
    J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
    J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors.
    Li W; Huang B; Kang D; De Clercq E; Daelemans D; Pannecouque C; Zhan P; Liu X
    Chem Biol Drug Des; 2016 Sep; 88(3):380-5. PubMed ID: 27062197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Yu M; Li Z; Liu S; Fan E; Pannecouque C; De Clercq E; Liu X
    ChemMedChem; 2011 May; 6(5):826-33. PubMed ID: 21322110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs.
    Liu Z; Tian Y; Liu J; Huang B; Kang D; De Clercq E; Daelemans D; Pannecouque C; Zhan P; Liu X
    Eur J Med Chem; 2017 Nov; 140():383-391. PubMed ID: 28987601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
    He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.
    He Y; Chen F; Sun G; Wang Y; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3173-6. PubMed ID: 15149669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series.
    Vig R; Mao C; Venkatachalam TK; Tuel-Ahlgren L; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1461-6. PubMed ID: 9873370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
    Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
    J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity.
    Sbardella G; Mai A; Artico M; Chimenti P; Massa S; Loddo R; Marongiu ME; La Collat P; Pani A
    Antivir Chem Chemother; 2001 Jan; 12(1):37-50. PubMed ID: 11437321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors.
    Fang Z; Kang D; Zhang L; Huang B; Liu H; Pannecouque C; De Clercq E; Zhan P; Liu X
    Chem Biol Drug Des; 2015 Oct; 86(4):614-8. PubMed ID: 25626467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.
    Uckun FM; Mao C; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Venkatachalam TK
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2721-6. PubMed ID: 10509923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
    Gao P; Song S; Wang Z; Sun L; Zhang J; Pannecouque C; De Clercq E; Zhan P; Liu X
    Bioorg Med Chem; 2021 Jun; 40():116195. PubMed ID: 33979774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach.
    Wang L; Tian Y; Chen W; Liu H; Zhan P; Li D; Liu H; De Clercq E; Pannecouque C; Liu X
    Eur J Med Chem; 2014 Oct; 85():293-303. PubMed ID: 25089812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
    Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Yu M; Liu X; Li Z; Liu S; Pannecouque C; Clercq ED
    Bioorg Med Chem; 2009 Nov; 17(22):7749-54. PubMed ID: 19819705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1
    Wu Y; Tang C; Rui R; Yang L; Ding W; Wang J; Li Y; Lai CC; Wang Y; Luo R; Xiao W; Zhang H; Zheng Y; He Y
    Acta Pharm Sin B; 2020 Mar; 10(3):512-528. PubMed ID: 32140396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.